{"count": 2, "results": [{"_id": "37928155", "pmid": 37928155, "pmcid": "PMC10621799", "title": "Mechanisms and effects of metformin on skeletal muscle disorders", "journal": "Front Neurol", "authors": ["Shang R", "Miao J"], "date": "2023-10-19T00:00:00Z", "doi": "10.3389/fneur.2023.1275266", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1275266", "score": 50258.844, "text_hl": "A clinical study showed that combined treatment with @CHEMICAL_Arginine @CHEMICAL_MESH:D001120 @@@L-arginine@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ positively affected @<m>DISEASE_Hypokinesia</m> @DISEASE_MESH:D018476 @@@hypokines", "citations": {"NLM": "Shang R, Miao J. Mechanisms and effects of metformin on skeletal muscle disorders Front Neurol. 2023;14():1275266. PMID: 37928155", "BibTeX": "@article{37928155, title={Mechanisms and effects of metformin on skeletal muscle disorders}, author={Shang R and Miao J}, journal={Front Neurol}, volume={14}, pages={1275266}}"}}, {"_id": "39181309", "pmid": 39181309, "title": "Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["Zhao Y", "Fei L", "Duan Y"], "date": "2024-08-22T00:00:00Z", "doi": "10.1016/j.pnpbp.2024.111128", "meta_date_publication": "2024 Aug 22", "meta_volume": "135", "meta_issue": "", "meta_pages": "111128", "score": 50233.816, "text_hl": "RESULTS: Among 11,729 cases of motor adverse events in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ @SPECIES_9606 @@@patients@@@, six categories of @DISEASE_Diabetes_Complications @DISEASE_MESH:D048909 @@@drMD@@@ were significantly associated with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ medications. Noticeably, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was revealed to drastically increase the incidence of @DISEASE_Parkinson_Disease_Secondary @DISEASE_MESH:D010302 @@@parkinsonism@@@ (adjusted ROR:3.97; 95 %CI (3.03, 5.19), p = 5.68e-24), @<m>DISEASE_Hypokinesia</m> @DISEASE_MESH:D018476 @@@bradykinesia@@@ (adjusted ROR:1.69; 95 %CI (1.07,2.59), p = 0.02) and irregular @DISEASE_Hyperkinesis @DISEASE_MESH:D006948 @@@hyperkinesia@@@, including @DISEASE_Chorea @DISEASE_MESH:D002819 @@@chorea@@@, @DISEASE_Choreoathetosis_Hypothyroidism_And_Neonatal_Respiratory_Distress @DISEASE_MESH:C567034 @@@choreoathetosis@@@ and @DISEASE_Athetosis @DISEASE_MESH:D001264 @@@athetosis@@@. ", "citations": {"NLM": "Zhao Y, Fei L, Duan Y. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 22;135():111128. PMID: 39181309", "BibTeX": "@article{39181309, title={Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.}, author={Zhao Y and Fei L and Duan Y}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={135}, pages={111128}}"}}]}